Skip to main content
Clinical Trials/CTRI/2023/10/058670
CTRI/2023/10/058670
Recruiting
Phase 4

Impact of Hyperbaric Oxygen Therapy (HBOT) in cerebral vasospasm after Sub-Arachnoid Hemorrhage (SAH) - a comparison study with and without HBOT

Amrita Institute of Medical Sciences0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: I609- Nontraumatic subarachnoid hemorrhage, unspecified
Sponsor
Amrita Institute of Medical Sciences
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • First time SAH
  • Cerebral vasospasm with clinical cognitive decline and neurological deficits

Exclusion Criteria

  • Hemodynamic instability
  • Previous history CVA
  • Neurodegenerative diseases
  • Deformities
  • Amputations
  • Middle ear barotrauma
  • Chronic otitis media
  • Chronic obstructive pulmonary disease
  • Pulmonary blebs
  • Clinical depression impeding rehabilitation compliance

Outcomes

Primary Outcomes

Not specified

Similar Trials